
Cligosiban
CAS No. 900510-03-4
Cligosiban( PF-3274167 | PF 03274167 )
Catalog No. M16474 CAS No. 900510-03-4
A potent, specific oxytocin receptor antagonist with Ki of 9.5 nM, displays high selectivity over the vasopressin receptors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
![]() ![]() |
10MG | 68 | In Stock |
![]() ![]() |
25MG | 143 | In Stock |
![]() ![]() |
50MG | 230 | In Stock |
![]() ![]() |
100MG | 370 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCligosiban
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific oxytocin receptor antagonist with Ki of 9.5 nM, displays high selectivity over the vasopressin receptors.
-
DescriptionA potent, specific oxytocin receptor antagonist with Ki of 9.5 nM, displays high selectivity over the vasopressin receptors; demonstrates excellent potency and selectivity, as well as promising in vivo pharmacokinetics and significantly improved aqueous solubility.Sexual Dysfunction Phase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-3274167 | PF 03274167
-
PathwayGPCR/G Protein
-
TargetOXTR
-
RecptorOXTR
-
Research AreaEndocrinology
-
IndicationSexual Dysfunction
Chemical Information
-
CAS Number900510-03-4
-
Formula Weight419.841
-
Molecular FormulaC19H19ClFN5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCOC1=NC=C(N2C(N3CC(OC4=CC=C(F)C=C4Cl)C3)=NN=C2COC)C=C1
-
Chemical Name5-(3-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-5-(methoxymethyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vidal B, et al. Nucl Med Biol. 2017 Dec;55:1-6.
2. Brown A, et al. Bioorg Med Chem Lett. 2010 Jan 15;20(2):516-20.
molnova catalog



related products
-
Cligosiban
A potent, specific oxytocin receptor antagonist with Ki of 9.5 nM, displays high selectivity over the vasopressin receptors.
-
Atosiban
A nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist.